ASTH
Astrana Health Inc. · NASDAQ
- Sector Health Services
- Industry Services to the Health Industry
- Website apollomed.net
- Employees(FY) 1362
- ISIN US03763A2078
Performance
+3.83%
1W
-9.78%
1M
-13.18%
3M
-31.77%
6M
-18.33%
YTD
-33.77%
1Y
Profile
Apollo Medical Holdings, Inc., a physician-centric technology-powered healthcare company, provides medical care services in the United States. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients in California. The company was incorporated in 1985 and is headquartered in Alhambra, California.
Technical Analysis of ASTH 2025-06-13
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-06-02 16:56
- 2025-03-17 17:09
2 Reasons to Like ASTH and 1 to Stay Skeptical(Stockstory)
- 2025-02-27 13:46
- 2025-02-26 03:05
- 2025-02-20 01:00
CVS Health Stock Gets RS Rating Upgrade(Yahoo Finance)
- 2025-02-10 06:45
- 2025-02-04 19:00
ASTH: Lowering target price to $39.00(Argus Research)
- 2025-01-28 19:00
ASTH: Raising target price to $40.00(Argus Research)
- 2025-01-22 07:51
- 2025-01-21 19:00
ASTH: Raising target price to $39.00(Argus Research)
- 2025-01-21 07:45
- 2025-01-20 18:45
- 2025-01-15 14:41
Is Astrana Health, Inc. (NASDAQ:ASTH) Potentially Undervalued?(Simply Wall St.)
- 2025-01-14 19:00
ASTH: What does Argus have to say about ASTH?(Argus Research)
- 2025-01-08 15:37
Prospect Medical Explores Restructuring(The Wall Street Journal)
- 2025-01-07 19:00
ASTH: Lowering target price to $33.00(Argus Research)
Page 1 of 1
previousnext
Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.